1.17

10.69% -0.14

After Hours: 1.20 0.03 +2.56%

Tiziana Life Sciences Ltd (TLSA)

Overview News Price History Option Chain Discussions Forecast Stock Split

Tiziana Life Sciences Ltd stock is traded at $1.17, with a volume of 291.74K. It is down -10.69% in the last 24 hours and down -5.65% over the past month. Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Previous Close:

$1.31

Open:

$1.3

24h Volume:

291.74K

Relative Volume:

1.43

Market Cap:

$148.89M

Revenue:

Net Income/Loss:

$-18.43M

P/E Ratio:

-7.5096

EPS:

-0.1558

Net Cash Flow:

$-12.87M

1W Performance:

-4.88%

1M Performance:

-5.65%

6M Performance:

-20.95%

1Y Performance:

-22.52%

1-Day Range:

$1.13

$1.32

1-Week Range:

$1.13

$1.32

52-Week Range:

$1.04

$2.60

Tiziana Life Sciences Ltd Stock (TLSA) Company Profile

Name

Tiziana Life Sciences Ltd

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

Address

Employee

Twitter

@tizianals

Next Earnings Date

2026-08-07

Latest SEC Filings

TLSA's Discussions on Twitter

Compare TLSA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLSA Tiziana Life Sciences Ltd	1.17	162.89M	0	-18.43M	-12.87M	-0.1558
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-22-20	Initiated	B. Riley Securities	Buy
Dec-17-18	Initiated	Laidlaw	Buy

Tiziana Life Sciences Ltd Stock (TLSA) Latest News

Jun 27, 2026

Small cap wrap: Power Metallic Mines, Tiziana Life Sciences, Fox Tungsten, American Resources… - Proactive financial news

Jun 25, 2026

0RP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Could Intranasal Innovation Shape the Future of Multiple Sclerosis Care? - Kalkine Media

Jun 25, 2026

Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada

Jun 25, 2026

Tiziana Life Sciences (TLSA) Advances Clinical Trial for Multiple Sclerosis Treatment - GuruFocus

Jun 25, 2026

Tiziana Life Sciences Doses Last Patient in Phase 2 Trial of Potential Multiple Sclerosis Treatment - Moomoo

Jun 25, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 25, 2026

Tiziana (Nasdaq: TLSA) completes enrollment in Phase 2a INFORM-MS study - Stock Titan

Jun 25, 2026

Tiziana doses final INFORM-MS patient ahead of late-2026 data - Stock Titan

Jun 25, 2026

Jun 23, 2026